• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎中的骨侵蚀:机制、诊断与治疗。

Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment.

机构信息

Department of Internal Medicine 3, University of Erlangen-Nuremberg, Krankenhausstrasse 12, 91054 Erlangen, Germany.

出版信息

Nat Rev Rheumatol. 2012 Nov;8(11):656-64. doi: 10.1038/nrrheum.2012.153. Epub 2012 Sep 25.

DOI:10.1038/nrrheum.2012.153
PMID:23007741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4096779/
Abstract

Bone erosion is a central feature of rheumatoid arthritis and is associated with disease severity and poor functional outcome. Erosion of periarticular cortical bone, the typical feature observed on plain radiographs in patients with rheumatoid arthritis, results from excessive local bone resorption and inadequate bone formation. The main triggers of articular bone erosion are synovitis, including the production of proinflammatory cytokines and receptor activator of nuclear factor κB ligand (RANKL), as well as antibodies directed against citrullinated proteins. Indeed, both cytokines and autoantibodies stimulate the differentiation of bone-resorbing osteoclasts, thereby stimulating local bone resorption. Although current antirheumatic therapy inhibits both bone erosion and inflammation, repair of existing bone lesions, albeit physiologically feasible, occurs rarely. Lack of repair is due, at least in part, to active suppression of bone formation by proinflammatory cytokines. This Review summarizes the substantial progress that has been made in understanding the pathophysiology of bone erosions and discusses the improvements in the diagnosis, monitoring and treatment of such lesions.

摘要

骨侵蚀是类风湿关节炎的一个核心特征,与疾病严重程度和不良功能结局相关。骨侵蚀发生于骨皮质,是类风湿关节炎患者平片上的典型表现,是由局部骨吸收过度和骨形成不足引起的。关节骨侵蚀的主要触发因素是滑膜炎,包括促炎细胞因子和核因子 κB 配体(receptor activator of nuclear factor κB ligand,RANKL)的产生,以及针对瓜氨酸化蛋白的抗体。事实上,细胞因子和自身抗体都能刺激破骨细胞的分化,从而刺激局部骨吸收。虽然目前的抗风湿疗法能抑制骨侵蚀和炎症,但现有骨损伤的修复虽然在生理上可行,但很少发生。修复缺乏的原因至少部分是由促炎细胞因子对骨形成的主动抑制所致。本文总结了在理解骨侵蚀病理生理学方面取得的重大进展,并讨论了这些病变的诊断、监测和治疗的改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21ac/4096779/9b3621664cb5/nihms601272f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21ac/4096779/ec456bc028ed/nihms601272f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21ac/4096779/9e8fcc54e783/nihms601272f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21ac/4096779/c3a286dcf6f3/nihms601272f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21ac/4096779/9b3621664cb5/nihms601272f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21ac/4096779/ec456bc028ed/nihms601272f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21ac/4096779/9e8fcc54e783/nihms601272f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21ac/4096779/c3a286dcf6f3/nihms601272f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21ac/4096779/9b3621664cb5/nihms601272f4.jpg

相似文献

1
Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment.类风湿关节炎中的骨侵蚀:机制、诊断与治疗。
Nat Rev Rheumatol. 2012 Nov;8(11):656-64. doi: 10.1038/nrrheum.2012.153. Epub 2012 Sep 25.
2
Rheumatoid Arthritis in the View of Osteoimmunology.骨免疫学视角下的类风湿关节炎
Biomolecules. 2020 Dec 31;11(1):48. doi: 10.3390/biom11010048.
3
Pathogenesis of bone erosions in rheumatoid arthritis.类风湿关节炎中骨侵蚀的发病机制。
Curr Opin Rheumatol. 2000 May;12(3):195-9. doi: 10.1097/00002281-200005000-00006.
4
Fc-gamma receptors and S100A8/A9 cause bone erosion during rheumatoid arthritis. Do they act as partners in crime?Fc-γ 受体和 S100A8/A9 在类风湿关节炎中导致骨质侵蚀。它们是否是同谋?
Rheumatology (Oxford). 2019 Aug 1;58(8):1331-1343. doi: 10.1093/rheumatology/kez218.
5
Bone and joint destruction in rheumatoid arthritis: what is really happening?类风湿关节炎中的骨与关节破坏:究竟发生了什么?
J Rheumatol Suppl. 2002 Sep;65:44-8.
6
[Inflammation and osteoclasts].[炎症与破骨细胞]
Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(5):367-376. doi: 10.2177/jsci.40.367.
7
RANK, RANKL and osteoprotegerin in arthritic bone loss.关节炎性骨质流失中的RANK、RANKL和骨保护素
Braz J Med Biol Res. 2005 Feb;38(2):161-70. doi: 10.1590/s0100-879x2005000200004. Epub 2005 Feb 15.
8
Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts.类风湿关节炎中的关节侵蚀:肿瘤坏死因子α、白细胞介素1和核因子κB受体激活剂配体(RANKL)之间的相互作用调节破骨细胞。
Ann Rheum Dis. 2004 Apr;63(4):354-9. doi: 10.1136/ard.2003.008458.
9
Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis.类风湿关节炎血管翳组织中RANKL与骨保护素mRNA的表达失衡
Clin Exp Rheumatol. 2008 Mar-Apr;26(2):240-6.
10
Periarticular Bone Loss in Arthritis Is Induced by Autoantibodies Against Citrullinated Vimentin.关节炎关节周围骨丢失是由抗瓜氨酸波形蛋白自身抗体引起的。
J Bone Miner Res. 2017 Aug;32(8):1681-1691. doi: 10.1002/jbmr.3158. Epub 2017 May 26.

引用本文的文献

1
Bone Marrow Adipoq-lineage Progenitors: an Emerging Osteoclast Niche Cell Population.骨髓脂肪细胞系祖细胞:一种新兴的破骨细胞微环境细胞群体。
Curr Osteoporos Rep. 2025 Sep 12;23(1):37. doi: 10.1007/s11914-025-00933-2.
2
Microenvironment-driven transformable self-assembly nanoplatform enables spatiotemporal remodeling for rheumatoid arthritis therapy.微环境驱动的可转化自组装纳米平台实现类风湿性关节炎治疗的时空重塑。
Sci Adv. 2025 Sep 5;11(36):eadu5245. doi: 10.1126/sciadv.adu5245. Epub 2025 Sep 3.
3
Beyond inflammation: the molecular basis of bone remodeling in axial spondyloarthritis and psoriatic arthritis.

本文引用的文献

1
Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.托法替尼或阿达木单抗与安慰剂治疗类风湿关节炎的比较。
N Engl J Med. 2012 Aug 9;367(6):508-19. doi: 10.1056/NEJMoa1112072.
2
Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis.托法替尼单药治疗类风湿关节炎的安慰剂对照试验。
N Engl J Med. 2012 Aug 9;367(6):495-507. doi: 10.1056/NEJMoa1109071.
3
Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study.白介素-6 受体阻断诱导类风湿关节炎骨侵蚀的有限修复:一项 micro CT 研究。
超越炎症:轴性脊柱关节炎和银屑病关节炎中骨重塑的分子基础
Front Immunol. 2025 Jul 31;16:1599995. doi: 10.3389/fimmu.2025.1599995. eCollection 2025.
4
Revolutionizing rheumatoid arthritis therapy: the potential of lipid nanocarriers.革新类风湿性关节炎治疗:脂质纳米载体的潜力
RSC Adv. 2025 Aug 1;15(33):27388-27402. doi: 10.1039/d5ra04258e. eCollection 2025 Jul 25.
5
PCK1 as a potential hub gene in distinguishing lactate metabolism between rheumatoid arthritis and osteoarthritis.PCK1作为区分类风湿性关节炎和骨关节炎乳酸代谢的潜在枢纽基因。
PeerJ. 2025 Jul 31;13:e19661. doi: 10.7717/peerj.19661. eCollection 2025.
6
Synovial infiltrating immune cell heterogeneity associated with synovitis severity and systemic disease activity in rheumatoid arthritis: a cross-sectional study.类风湿关节炎中与滑膜炎严重程度和全身疾病活动相关的滑膜浸润免疫细胞异质性:一项横断面研究。
Clin Rheumatol. 2025 Jul 30. doi: 10.1007/s10067-025-07565-y.
7
Mitochondria as a Disease-Relevant Organelle in Rheumatoid Arthritis: A Key Breakout in Fight Against the Disease.线粒体作为类风湿关节炎中与疾病相关的细胞器:对抗该疾病的关键突破
Biomedicines. 2025 Jul 13;13(7):1708. doi: 10.3390/biomedicines13071708.
8
Proteomic Profiling Reveals Novel Molecular Insights into Dysregulated Proteins in Established Cases of Rheumatoid Arthritis.蛋白质组学分析揭示了类风湿关节炎确诊病例中失调蛋白质的新分子见解。
Proteomes. 2025 Jul 4;13(3):32. doi: 10.3390/proteomes13030032.
9
Phytochemical modulation of mTOR signaling: emerging nanotechnology-driven therapeutics for rheumatoid arthritis management.mTOR信号通路的植物化学调控:新兴的纳米技术驱动的类风湿关节炎治疗方法
Inflammopharmacology. 2025 Jul 22. doi: 10.1007/s10787-025-01844-5.
10
Cellular composition of tissue-resident monocyte-lineage cells reveal functional heterogeneity during inflammatory arthritis.组织驻留单核细胞系细胞的细胞组成揭示了炎症性关节炎期间的功能异质性。
bioRxiv. 2025 Jun 18:2025.06.13.659432. doi: 10.1101/2025.06.13.659432.
Ann Rheum Dis. 2013 Mar;72(3):396-400. doi: 10.1136/annrheumdis-2011-201075. Epub 2012 May 14.
4
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.人抗瓜氨酸化波形蛋白自身抗体诱导破骨细胞生成和骨丢失。
J Clin Invest. 2012 May;122(5):1791-802. doi: 10.1172/JCI60975. Epub 2012 Apr 16.
5
Effect of rheumatoid arthritis on volumetric bone mineral density and bone geometry, assessed by peripheral quantitative computed tomography in postmenopausal women treated with bisphosphonates.类风湿关节炎对接受双膦酸盐治疗的绝经后女性骨体积密度和骨几何形态的影响,通过外周定量计算机断层扫描评估。
J Rheumatol. 2012 Jun;39(6):1215-20. doi: 10.3899/jrheum.110579. Epub 2012 Apr 1.
6
Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study.IL15 基因变异与类风湿关节炎关节破坏进展相关:一项多队列研究。
Ann Rheum Dis. 2012 Oct;71(10):1651-7. doi: 10.1136/annrheumdis-2011-200724. Epub 2012 Mar 22.
7
Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.小剂量泼尼松加入甲氨蝶呤为基础的紧密控制策略治疗早期类风湿关节炎:一项随机试验。
Ann Intern Med. 2012 Mar 6;156(5):329-39. doi: 10.7326/0003-4819-156-5-201203060-00004.
8
The pathogenesis of rheumatoid arthritis.类风湿关节炎的发病机制。
N Engl J Med. 2011 Dec 8;365(23):2205-19. doi: 10.1056/NEJMra1004965.
9
Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway.炎症的消退可诱导成骨细胞功能并调节Wnt信号通路。
Arthritis Rheum. 2012 May;64(5):1540-50. doi: 10.1002/art.33504.
10
Anti IL-17A therapy inhibits bone loss in TNF-α-mediated murine arthritis by modulation of the T-cell balance.抗白介素-17A 治疗通过调节 T 细胞平衡抑制 TNF-α 介导的小鼠关节炎中的骨丢失。
Eur J Immunol. 2012 Feb;42(2):413-23. doi: 10.1002/eji.201141871. Epub 2011 Dec 20.